Expert Opinion on Emerging Drugs, pages 1-13

A comprehensive review of phase 2/3 trials in osteoarthritis: an expert opinion

Liyang Pan ^{1, 2}

Lydia Nagib ^{3, 4}

Sujata Ganguly ^{5, 6}

Arumugam Moorthy ^{5, 6}

Hasan Tahir ^{3, 4, 7, 8}

Hide authors affiliations

Imperial College Healthcare NHS trust, London, UK |

General internal medicine, Imperial College Healthcare NHS Trust, London, UK |

Royal Free London NHS foundation Trust, London, UK |

⁴

General internal medicine, Royal Free London NHS Foundation Trust, London, UK

⁵

University Hospitals Of Leicester NHS Trust, Leicester, UK |

⁶

Department of Rheumatology, University Hospitals of Leicester NHS Trust, Leicester, UK |

⁷

University College London, London, UK |

⁸

Department of Rheumatology, University College London, London, UK |

Publication type: Journal Article

Publication date: 2024-08-05

Taylor & Francis

Journal: Expert Opinion on Emerging Drugs

scimago Q1

wos Q2

SJR: 0.881

CiteScore: 5.9

Impact factor: 2.7

ISSN: 14728214, 17447623

DOI: 10.1080/14728214.2024.2386174

Copy DOI

Found

	1
Journal of Orthopaedic Surgery and Research	Journal of Orthopaedic Surgery and Research, 1, 100% Journal of Orthopaedic Surgery and Research 1 publication, 100%
	1

	1
Springer Nature	Springer Nature, 1, 100% Springer Nature 1 publication, 100%
	1

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.

Metrics

Cite this

GOST | RIS | BibTex

Found error?

Publisher

Taylor & Francis

Journal

Expert Opinion on Emerging Drugs

scimago Q1

wos Q2

SJR

0.881

CiteScore

5.9

Impact factor

2.7

ISSN

14728214 (Print)

17447623 (Electronic)

A comprehensive review of phase 2/3 trials in osteoarthritis: an expert opinion

Top-30

Journals

Publishers

Are you a researcher?